Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder March 5, 2026 7:30 AM ESTCompany ParticipantsMichael Cola - ...

SE has achieved rapid commercial success with VYVGART, driving $4.2 billion in 2025 sales and operational profitability. Learn more about ARGX stock here.

Individuals with chronic back pain reported significantly higher levels of auditory sensitivity compared with pain-free controls, but therapy may mitigate this sensitivity, according to findings ...

Decapitation without consolidation creates vacuums. Vacuums do not remain empty for long ...

NORRISTOWN — Prosecutors want to call an expert in the subculture of outlaw motorcycle gangs to educate jurors about such groups when nine members of the Pagans biker club head to trial later this ...

Kevin Skarupa's forecast ...

Winter weather moved into the Granite State Thursday evening, starting as rain before changing to freezing rain and snow ...

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 - NMD Pharma A/S, a clinical-sta ...

Women benefit from planning before conception ...

Shanghai-based Tenacia Biotechnology is making a $308 million biobucks move for Rapport Therapeutics' leading asset focused on focal onset seizures (FOS) and primary generalized tonic-clonic seizures, ...